BioCryst's market cap is currently $1.94B. The company's EPS TTM is $-0.607; its P/E ratio is ―; BioCryst is scheduled to report earnings on February 19, 2025, and the estimated EPS forecast is $-0.05. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 331.41M	$ 270.83M	$ 157.17M	$ 17.81M	$ 48.84M
Gross Profit	$ 326.75M	$ 264.23M	$ 149.91M	$ 16.14M	$ 44.73M
Operating Income	$ -103.71M	$ -148.44M	$ -177.72M	$ -174.76M	$ -99.45M
EBITDA	$ -116.33M	$ -143.85M	$ -121.74M	$ -167.56M	$ -96.28M
Net Income	$ -226.54M	$ -247.12M	$ -184.06M	$ -196.57M	$ -120.06M
Balance Sheet
Cash & Short-Term Investments	$ 388.99M	$ 442.39M	$ 514.43M	$ 300.37M	$ 136.23M
Total Assets	$ 516.96M	$ 550.00M	$ 588.15M	$ 334.71M	$ 175.28M
Total Debt	$ 848.71M	$ 741.45M	$ 593.24M	$ 124.72M	$ 84.65M
Net Debt	$ 714.50M	$ 436.69M	$ 88.85M	$ -147.41M	$ -29.52M
Total Liabilities	$ 972.49M	$ 844.60M	$ 695.14M	$ 353.98M	$ 137.03M
Stockholders' Equity	$ -455.53M	$ -1.45B	$ -1.21B	$ -1.02B	$ -840.63M
Cash Flow
Free Cash Flow	$ -97.31M	$ -163.20M	$ -144.54M	$ -137.73M	$ -89.93M
Operating Cash Flow	$ -95.14M	$ -161.85M	$ -142.16M	$ -137.22M	$ -89.58M
Investing Cash Flow	$ -131.50M	$ -128.24M	$ 15.80M	$ -6.86M	$ 77.93M
Financing Cash Flow	$ 32.48M	$ 88.03M	$ 359.67M	$ 302.70M	$ 99.10M

Currency in USD

BioCryst Earnings and Revenue History

Income Statement >

BioCryst Debt to Assets

Balance Sheet >

BioCryst Cash Flow

Cash Flow >

BioCryst Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing